Kesler Norman & Wride’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-27,477
Closed -$703K 161
2023
Q3
$703K Hold
27,477
0.18% 120
2023
Q2
$720K Hold
27,477
0.17% 114
2023
Q1
$717K Sell
27,477
-540
-2% -$14.1K 0.18% 115
2022
Q4
$769K Buy
28,017
+540
+2% +$14.8K 0.2% 110
2022
Q3
$661K Buy
+27,477
New +$661K 0.18% 124